Get notified when TYRA files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTyra Biosciences separates accounting officer role, promotes Julia Rueb from CFO duties
Filed April 2, 2026 · Period ending April 1, 2026 · ~1 min read
Key Changes
-
low
Julia Rueb, VP of Finance, designated as principal accounting officer effective April 1, 2026, taking over accounting responsibilities from CFO Alan Fuhrman who retains principal financial officer role.
Item 5.02 verify on EDGAR → -
low
Rueb has been with Tyra since October 2022, serving as Corporate Controller before promotion to VP Finance in January 2024; she is a CPA with prior Ernst & Young experience in life sciences.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade TYRA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify